14-day Premium Trial Subscription Try For FreeTry Free
Date Action Amount Person Type
Apr 01, 2024 Buy 1 389 Anderson Kenneth Carl Common Stock
Apr 01, 2024 Buy 1 358 Dubin Glenn Common Stock
Apr 01, 2024 Buy 1 697 Grogan Donna Roy Common Stock
Mar 07, 2024 Buy 115 000 Boyle Scott N Stock Option (Right to Buy)
Mar 07, 2024 Sell 115 000 Boyle Scott N Stock Option (Right to Buy)
Mar 07, 2024 Buy 118 000 Fisher Stewart Stock Option (Right to Buy)
Mar 07, 2024 Buy 94 950 Fisher Stewart Stock Option (Right to Buy)
Mar 07, 2024 Sell 94 950 Fisher Stewart Stock Option (Right to Buy)
Mar 07, 2024 Sell 118 000 Fisher Stewart Stock Option (Right to Buy)
Mar 07, 2024 Buy 92 000 Schick Kelly Stock Option (Right to Buy)
Mar 07, 2024 Buy 78 500 Schick Kelly Stock Option (Right to Buy)
Mar 07, 2024 Sell 92 000 Schick Kelly Stock Option (Right to Buy)
Mar 07, 2024 Sell 78 500 Schick Kelly Stock Option (Right to Buy)
Mar 07, 2024 Buy 45 000 Adams Kendra Stock Option (Right to Buy)
Mar 07, 2024 Sell 45 000 Adams Kendra Stock Option (Right to Buy)
Mar 07, 2024 Buy 90 000 Siegel Jolie Stock Option (Right to Buy)
Mar 07, 2024 Buy 84 850 Siegel Jolie Stock Option (Right to Buy)
Mar 07, 2024 Sell 90 000 Siegel Jolie Stock Option (Right to Buy)
Mar 07, 2024 Sell 84 850 Siegel Jolie Stock Option (Right to Buy)
Feb 15, 2024 Sell 6 560 Hirsch Andrew Common Stock
Feb 14, 2024 Buy 27 430 Mossler Mark Stock Option (Right to Buy)
Feb 14, 2024 Buy 18 290 Mossler Mark Common Stock
Feb 14, 2024 Buy 465 500 Hirsch Andrew Stock Option (Right to Buy)
Feb 14, 2024 Buy 103 400 Hirsch Andrew Common Stock
Feb 14, 2024 Buy 165 300 Reyno Leonard Stock Option (Right to Buy)
Feb 14, 2024 Buy 36 700 Reyno Leonard Common Stock
Feb 14, 2024 Buy 122 800 Siegel Jolie Stock Option (Right to Buy)
Feb 14, 2024 Buy 27 300 Siegel Jolie Common Stock
Feb 14, 2024 Buy 122 800 Schick Kelly Stock Option (Right to Buy)
Feb 14, 2024 Buy 27 300 Schick Kelly Common Stock
Feb 14, 2024 Buy 27 300 Fisher Stewart Common Stock
Feb 14, 2024 Buy 122 800 Fisher Stewart Stock Option (Right to Buy)
Feb 14, 2024 Buy 122 800 Boyle Scott N Stock Option (Right to Buy)
Feb 14, 2024 Buy 27 300 Boyle Scott N Common Stock
Feb 14, 2024 Buy 165 300 Adams Kendra Stock Option (Right to Buy)
Feb 14, 2024 Buy 36 700 Adams Kendra Common Stock
Feb 13, 2024 Sell 1 735 Siegel Jolie Common Stock
Feb 13, 2024 Sell 1 735 Schick Kelly Common Stock
Feb 13, 2024 Sell 2 255 Fisher Stewart Common Stock
Feb 13, 2024 Sell 1 735 Boyle Scott N Common Stock
Feb 13, 2024 Sell 1 301 Adams Kendra Common Stock
Jan 02, 2024 Buy 1 687 Dubin Glenn Common Stock
Jan 02, 2024 Buy 1 725 Anderson Kenneth Carl Common Stock
Jan 02, 2024 Buy 2 108 Grogan Donna Roy Common Stock
Nov 16, 2023 Buy 52 000 Hughes Owen Stock Option (Right to Buy)
Nov 16, 2023 Buy 0 Hughes Owen
Oct 02, 2023 Buy 6 617 Anderson Kenneth Carl Common Stock
Oct 02, 2023 Buy 6 470 Dubin Glenn Common Stock
Oct 02, 2023 Buy 8 089 Grogan Donna Roy Common Stock
Sep 18, 2023 Buy 489 600 Hirsch Andrew Stock Option (Right to Buy)
Sep 18, 2023 Buy 120 000 Schick Kelly Stock Option (Right to Buy)
Sep 18, 2023 Buy 120 000 Fisher Stewart Stock Option (Right to Buy)
Sep 18, 2023 Buy 120 000 Boyle Scott N Stock Option (Right to Buy)
Sep 18, 2023 Buy 120 000 Siegel Jolie Stock Option (Right to Buy)
Sep 18, 2023 Buy 111 000 Adams Kendra Stock Option (Right to Buy)
Sep 18, 2023 Buy 25 000 Adams Kendra Common Stock
Sep 18, 2023 Buy 50 210 Mossler Mark Stock Option (Right to Buy)
Sep 18, 2023 Buy 0 Adams Kendra Common Stock
Sep 18, 2023 Buy 57 375 Adams Kendra Stock Option (Right to Buy)
Sep 18, 2023 Buy 45 000 Adams Kendra Stock Option (Right to Buy)
Sep 18, 2023 Buy 75 000 Adams Kendra Stock Option (Right to Buy)
Sep 18, 2023 Buy 16 500 Adams Kendra Performance Restricted Stock Units
Aug 30, 2023 Buy 7 500 Hirsch Andrew Common Stock
Aug 30, 2023 Sell 2 205 Hirsch Andrew Common Stock
Aug 30, 2023 Sell 7 500 Hirsch Andrew Performance Restricted Stock Units
Aug 30, 2023 Buy 2 250 Siegel Jolie Common Stock
Aug 30, 2023 Sell 661 Siegel Jolie Common Stock
Aug 30, 2023 Sell 2 250 Siegel Jolie Performance Restricted Stock Units
Aug 30, 2023 Buy 2 250 White Lauren Common Stock
Aug 30, 2023 Sell 661 White Lauren Common Stock
Aug 30, 2023 Sell 2 250 White Lauren Performance Restricted Stock Units
Aug 30, 2023 Buy 2 250 Schick Kelly Common Stock
Aug 30, 2023 Sell 661 Schick Kelly Common Stock
Aug 30, 2023 Sell 2 250 Schick Kelly Performance Restricted Stock Units
Aug 30, 2023 Buy 2 250 Fisher Stewart Common Stock
Aug 30, 2023 Sell 661 Fisher Stewart Common Stock
Aug 30, 2023 Sell 2 250 Fisher Stewart Performance Restricted Stock Units
Aug 30, 2023 Buy 2 250 Boyle Scott N Common Stock
Aug 30, 2023 Sell 661 Boyle Scott N Common Stock
Aug 30, 2023 Sell 2 250 Boyle Scott N Performance Restricted Stock Units
Jul 10, 2023 Buy 276 000 Reyno Leonard Stock Option (Right to Buy)
Jul 10, 2023 Buy 61 300 Reyno Leonard Common Stock
Jul 10, 2023 Buy 0 Reyno Leonard
Jul 03, 2023 Buy 3 976 Anderson Kenneth Carl Common Stock
Jul 03, 2023 Buy 3 887 Dubin Glenn Common Stock
Jul 03, 2023 Buy 4 858 Grogan Donna Roy Common Stock
Jun 15, 2023 Buy 26 000 Anderson Kenneth Carl Stock Option (Right to Buy)
Jun 15, 2023 Buy 26 000 Bessen Laura Stock Option (Right to Buy)
Jun 15, 2023 Buy 26 000 Downey Bruce Stock Option (Right to Buy)
Jun 15, 2023 Buy 26 000 Dubin Glenn Stock Option (Right to Buy)
Jun 15, 2023 Buy 26 000 Grogan Donna Roy Stock Option (Right to Buy)
Jun 15, 2023 Buy 26 000 Koppikar Utpal Stock Option (Right to Buy)
Jun 15, 2023 Buy 26 000 Salter Malcolm Stock Option (Right to Buy)
Apr 03, 2023 Buy 3 516 Anderson Kenneth Carl Common Stock
Apr 03, 2023 Buy 4 298 Grogan Donna Roy Common Stock
Feb 13, 2023 Buy 125 000 Fisher Stewart Stock Option (Right to Buy)
Feb 13, 2023 Buy 26 000 Fisher Stewart Common Stock
Feb 13, 2023 Buy 90 000 Siegel Jolie Stock Option (Right to Buy)
Feb 13, 2023 Buy 20 000 Siegel Jolie Common Stock
Feb 13, 2023 Buy 90 000 Boyle Scott N Stock Option (Right to Buy)
INSIDER POWER
64.346
Last 100 transactions
Buy: 4 679 730 | Sell: 757 881 (Shares)

Based on the 100 latest insides trades, we have calculated the insider power to be positive at a ratio of 64.346.

In total, the insiders bought 4 679 730 and sold 757 881 CCCC shares in the last 100 trades.

Click to get the best stock tips daily for free!

About C4 Therapeutics Inc

C4 Therapeutics C4 Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel therapeutic candidates to degrade disease-causing proteins for the treatment of cancer, neurodegenerative conditions, and other diseases. Its lead product candidate is CFT7455, an orally bioavailable MonoDAC degrader of protein that is in Phase 1/2 trial targeting IKZF1 and IKZF3 for multiple myeloma and non-Hodgkin lymphomas, including peripheral T-cell lymphoma an... CCCC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT